Role of L-citrulline in Prevention of Pregnancy Associated Hypertension

Summary

The target population for our study is healthy nulliparous pregnant women (first pregnancy) between the 12-16 week of pregnancy. If a subject is eligible, written consent will be obtained by person to person contact. Eligible participants will be randomized to receive either daily L-citrulline supplementation or placebo.

Timeline

Start

2021-07-28

Primary completion

2025-12-12

Completion

2025-12-12

Outcome

Outcome not reported

Stopped: “At the request of the PI”

Drugs

Indications